ARC Capital Invests $13 Million in Buchang Pharma
Published: Jul 06, 2011
July 5, 2011 -- ARC Capital Holdings of Hong Kong paid $13 million to acquire a minority interest in Buchang Pharmaceutical Group, a privately-owned TCM company. According to a news release, Buchang is the largest TCM company in China – if the judging standard is net profit. Buchang, which was founded in 1993, includes two hospitals and a university in addition to its portfolio of six pharma entities. More details....
Stock Symbol: (AIM: ARCH)